AHR · American Healthcare REIT, Inc.
$50.69
-0.57 (-1.11%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$11.29B
Shares
218.00M
Volume · Oct 1
2.88M
Avg daily vol (3M)
2.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$51.26
Open$51.80
Day$51.21–51.80
52W close$40.18–57.72
Avg vol 30d3.0M
Short int24.9M · 11.4% float · 9.3d
Short vol64%
Last earningsAug 7, 2026
DataFeb 2024–Sep 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 5 wks
filed Aug 7, 2026
call held Aug 7, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
0.5%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+22.0%
Trailing year
Short interest
11.4%
Latest settlement · 9.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Low
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
−6%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
63%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−9%
trailing
6-month return
+4%
trailing
YTD return
+9%
this year
Relative strength
−8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $55 › 200d $51 — 50d above 200d
Institutional flow
Accumulating
+10% holders QoQ · +98 funds added
Insider flow
Distributing
Net -$78.1K over 90 days · 100% sells
Short interest
Rising
11.41% of float · ▲ +17.6% MoM · 9.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
575 holders — near 2-yr high, broad support
Squeeze score
80
high risk · 0–100
Fundamentals
Revenue growth
+9%
Y/Y
EPS growth
+245%
Y/Y
Valuation
P/E 75.1
rich
Quant / Vol
risk profile
Volatility
26%
annualized · 1-yr
Max drawdown
−14%
past year
ATR
2.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Full Year 2026
Total Portfolio SS NOI Growth
Non-GAAP
Initiated
11% – 13%
SHOP Same-Store NOI Growth
Non-GAAP
Initiated
18% – 21%
ISHC Same-Store NOI Growth
Non-GAAP
Initiated
13% – 16%
Total Portfolio Same-Store NOI growth
Non-GAAP
Initiated
11% – 13%
General and administrative expenses
Initiated
$74M – $78M
Interest expense
Initiated
$75M – $79M
New development starts and on-going development projects funding
Initiated
$150M – $170M
FY 2026
Triple-Net Leased Properties Same-Store NOI Growth
Non-GAAP
Initiated
2% – 3%
Other income, net
Initiated
$5M – $8M
Funding for new development starts and on-going development proj
Initiated
$150M – $170M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
−6%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
63%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $55 › 200d $51 — 50d above 200d
Institutional flow
Accumulating
+10% holders QoQ · +98 funds added
Insider flow
Distributing
Net -$78.1K over 90 days · 100% sells
Short interest
Rising
11.41% of float · ▲ +17.6% MoM · 9.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
575 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $40
Now $51 · 63%
Range high $58
vs 200-day avg +1%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| NAREIT FFO attributable to controlling interest non-GAAP | 97.98M | Three Months Ended June 30, 2026 filing | — |
| Net operating income non-GAAP | 137.24M | Three Months Ended June 30, 2026 filing | — |
| Normalized FFO attributable to controlling interest non-GAAP | 105.19M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP NAREIT FFO attributable to controlling interest 97.98M
+2.79M Transaction, transition and restructuring costs
+300K Amortization of above- and below-market leases
+12K Amortization of closing costs — debt security investment
-354K Change in deferred rent
+5.77M Non-cash impact of changes to equity instruments
-223K Non-cash income tax benefit
-711K Capitalized interest
+147K Loss on debt extinguishments
-357K (Gain) loss in fair value of derivative financial instruments
-75K Foreign currency (gain) loss
+0K Adjustments for unconsolidated entities
-79K Adjustments for noncontrolling interests
= Normalized FFO attributable to controlling interest 105.19M
|
|||
| Segment net operating income non-GAAP | $137.24M | Three Months Ended June 30, 2026 filing | — |
| Annualized Cash NOI non-GAAP | 571.84M | as of June 30, 2026 | — |
| NAREIT FFO per common share attributable to controlling interest — diluted | $0.99 | Six Months Ended June 30, 2026 | — |
| Normalized FFO per common share attributable to controlling interest — diluted non-GAAP | $1.05 | Six Months Ended June 30, 2026 | — |
| Revenue per square foot | $32.29 | Q2 2026 | — |
| RevPOR | $5,754 | Q2 2026 | — |
| Same-Store NOI non-GAAP | 219.32M | Six Months Ended June 30, 2026 | — |
| Same-Store properties non-GAAP | 115 | Q2 2026 | — |
| Total average Occupancy | 89.5% | Q2 2026 | — |
| Trailing 12-months Retention | 65.2% | as of June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AHR
this stock
American Healthcare REIT, Inc.
|
$11.29B | +8.9% | +9.1% | 75.1 | 11.4% |
|
WELL
Welltower Inc.
|
$163.33B | +24.0% | +35.6% | 115.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$44.42B | +9.9% | +18.5% | 160.4 | 3.9% |
|
DOC
Healthpeak Properties, Inc.
|
$14.12B | +24.2% | +4.5% | 58.5 | 3.7% |
|
OHI
Omega Healthcare Investors Inc
|
$14.02B | +4.4% | +13.2% | 16.5 | 4.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AHR | -0.9% | -9.3% | +4.4% | -7.2% | +8.9% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -0.2% | -9.5% | -7.8% | -6.6% | -2.9% |
Capital returns
Latest dividend
$0.25
/ share · ex Sep 30, 2026
Paid (TTM)
$0.25
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.